This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: David Percival - Innovator in Pharmaceutical Compounds
Introduction
David Percival is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit COX-2 enzymes. His work has implications for various therapeutic applications.
Latest Patents
David Percival holds a patent for "Bisaryl COX-2 inhibiting compounds, compositions and methods of use." This invention relates to inhibitors of COX-2, which are crucial in managing inflammation and pain. The compounds are represented by a specific formula and include pharmaceutically acceptable salts and esters.
Career Highlights
David is associated with Merck Frosst Canada, Inc., where he has been involved in innovative research and development. His expertise in pharmaceutical compounds has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, David has worked alongside talented individuals such as Christopher I Bayly and Cameron Black. These collaborations have fostered a productive environment for innovation and discovery.
Conclusion
David Percival's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to influence the development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile